Public Dashboard: DnA's
| Dashboard: DnA's | Date: 05/13/2008 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Symbol | Shares | Price | Value | % of Total | Growth | Proj P/E | Proj Yield | Fin Str | EPS Stab | Qlty | PAR |
| Berkshire Hathaway B | BRK.B | 40 | $4,095.00 | $163,800 | 15.5% | 9.1% | 22.0 | 0.0% | 99% | 44 | 56.6 | 9.1% |
| Wrigley (Wm.) | WWY | 1000 | $77.40 | $77,400 | 7.3% | 13.0% | 27.0 | 1.6% | 96% | 100 | 82.9 | 5.2% |
| Johnson & Johnson | JNJ | 1000 | $66.71 | $66,710 | 6.3% | 7.0% | 19.0 | 2.2% | 100% | 98 | 75.3 | 14.0% |
| Procter & Gamble | PG | 1000 | $65.35 | $65,349 | 6.2% | 8.0% | 20.0 | 1.9% | 99% | 99 | 86.8 | 12.9% |
| Wells Fargo | WFC | 2000 | $29.76 | $59,520 | 5.6% | 12.3% | 14.0 | 2.9% | 98% | 81 | 76.5 | 16.5% |
| F.N.B. Corp* | FNB | 3000 | $15.44 | $46,320 | 4.4% | 3.3% | 13.0 | 5.2% | 41% | 73 | 50.1 | 8.1% |
| Stryker | SYK | 500 | $64.38 | $32,189 | 3.0% | 9.5% | 25.0 | 0.5% | 92% | 98 | 73.7 | 16.4% |
| Fastenal | FAST | 515 | $51.04 | $26,285 | 2.5% | 15.0% | 27.0 | 0.9% | 99% | 84 | 77.6 | 11.3% |
| Medtronic | MDT | 500 | $48.15 | $24,075 | 2.3% | 10.0% | 22.0 | 0.9% | 94% | 99 | 77.6 | 16.6% |
| Citigroup | C | 1000 | $23.64 | $23,640 | 2.2% | 5.8% | 11.0 | 4.2% | 61% | 81 | 56.6 | 18.5% |
| Kraft Foods | KFT | 692 | $31.36 | $21,701 | 2.1% | 3.5% | 19.0 | 2.4% | 56% | 77 | 59.3 | 11.9% |
| Altria Group (Prelim) | MO | 1000 | $21.58 | $21,580 | 2.0% | 5.0% | 10.0 | 4.1% | 89% | 91 | 75.6 | 4.9% |
| Allied Capital | ALD | 1000 | $21.26 | $21,260 | 2.0% | 9.0% | 12.0 | 7.0% | 72% | 35 | 40.3 | -0.7% |
| Pfizer | PFE | 1000 | $19.91 | $19,910 | 1.9% | 4.0% | 13.0 | 4.2% | 88% | 89 | 66.7 | 12.9% |
| Merck | MRK | 500 | $39.62 | $19,810 | 1.9% | 3.3% | 17.0 | 2.4% | 85% | 63 | 61.2 | 14.9% |
| Sanofi-Aventis | SNY | 500 | $36.93 | $18,465 | 1.7% | 7.0% | 18.0 | 2.8% | 91% | 93 | 68.7 | 13.9% |
| Chico's FAS | CHS | 2000 | $7.03 | $14,060 | 1.3% | 12.7% | 18.0 | 0.0% | 89% | 58 | 74.4 | 27.9% |
| E*Trade Group | ETFC | 3500 | $4.00 | $14,000 | 1.3% | 15.2% | 17.0 | 0.0% | 3% | 8 | 23.8 | 13.8% |
| Bristol-Myers Squibb | BMY | 500 | $21.63 | $10,815 | 1.0% | 9.0% | 19.0 | 3.3% | 56% | 57 | 54.2 | 17.3% |
| Stein Mart | SMRT | 2000 | $5.18 | $10,360 | 1.0% | 5.0% | 18.0 | 1.4% | 40% | 15 | 38.8 | 31.2% |
| Anheuser-Busch | BUD | 200 | $51.61 | $10,322 | 1.0% | 5.0% | 18.0 | 1.6% | 79% | 96 | 65.2 | 7.5% |
| Schering-Plough | SGP | 500 | $18.75 | $9,375 | 0.9% | 5.2% | 13.0 | 1.2% | 69% | 31 | 45.9 | 11.6% |
| Masco Corp. | MAS | 500 | $18.58 | $9,290 | 0.9% | 6.5% | 15.0 | 2.1% | 45% | 61 | 51.8 | 13.5% |
| TD Ameritrade | AMTD | 500 | $18.24 | $9,120 | 0.9% | 9.0% | 16.0 | 0.0% | 52% | 27 | 56.5 | 11.6% |
| Unisys | UIS | 2000 | $4.21 | $8,420 | 0.8% | 3.4% | 12.0 | 0.0% | 1% | 19 | 16.6 | 17.0% |
| Jack Henry | JKHY | 200 | $23.40 | $4,680 | 0.4% | 10.9% | 24.0 | 0.9% | 99% | 86 | 72.0 | 18.3% |
| Countrywide Financial | CFC | 500 | $4.79 | $2,395 | 0.2% | 9.0% | 9.0 | 3.2% | 3% | 23 | 24.5 | 39.2% |
| PWE | ||||||||||||
| Cash | $247,000 | 23.3% | 1.8% | 1.8% | ||||||||
| Totals & Averages | $1,057,853 | 100.0% | 8.6% | 19.2 | 1.9% | 84% | 73 | 65.9 | 9.5% | |||
| Portfolio Averages | |
|---|---|
| PAR | 9.5% |
| Quality | 65.9 |
| Growth | 8.6% |
| Average P/E Ratio | 19.2 |
| Average Yield | 1.9% |
| Financial Strength | 84 |
| EPS Stability | 73 |
| Quality Legend: | |
|---|---|
| Blue | Excellent with quality greater than 65. |
| Green | Good with quality between 55 and 65. |
| Neutral | Average or below average with quality between 35 and 55. |
| Red | Poor with quality less than 35. |
| PAR Legend: | |
| Green | PAR is within the target range of MIPAR +5-10%, currently 16.7-21.7%. |
| Yellow | PAR is above the target range of MIPAR +10%, currently 21.7%. |
| PAR | Projected Annual Return |
| MIPAR | The Manifest Investing Median PAR of all stocks in the database. |
| MIPAR | 11.7% |
| * | Not covered by Value Line Standard Edition. |
| b | Uses price-to-book value for valuation purposes. |
| ~ | Exhibits cyclical tendencies. |